Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers about its test kit.
The test is promoted as helping predict users' disease risk based on their DNA.
The lawsuit, filed in U.S. district court in California last week, comes days after the Food and Drug Administration ordered 23andMe to halt sales of its personalized test, saying the company failed to show that the technology is supported by science.
23andMe sells its $99 test online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.
The lawsuit by San Diego resident Lisa Casey alleges that the test results are "meaningless."
23andMe said Tuesday that it would not comment on legal matters.
Explore further: 23andMe identifies 5 significant genetic associations for hypothyroidism